$60M Catalyst Sale Gutted Company, Del. Investor Suit Says
A Catalyst Biosciences Inc. stockholder group has sued the company's directors for selling all its viable assets and keeping investors in the dark about plans for the $60 million in proceeds,...To view the full article, register now.
Already a subscriber? Click here to view full article